VIR BIOTECHNOLOGY
Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases. The company brings together cutting-edge innovations with scientific expertise and management. It seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. Vir Biotechnology also focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. T... he company four current technology platforms are designed to, either individually or in combination, stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Their vision is that one day, diseases like hepatitis B, influenza A, HIV, and tuberculosis become a thing of the past.
VIR BIOTECHNOLOGY
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2016-04-07
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vir.bio
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
793.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Visby Medical
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
PrognomiQ
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
UNITY Biotechnology
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-05-10 | Agenovir Corporation | Agenovir Corporation acquired by Vir Biotechnology | N/A |
| 2017-09-25 | Humabs | Humabs acquired by Vir Biotechnology | N/A |
| 2017-01-06 | TomegaVax | TomegaVax acquired by Vir Biotechnology | N/A |
Investors List
GlaxoSmithKline
GlaxoSmithKline investment in Post-IPO Equity - Vir Biotechnology
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Vir Biotechnology
Alta Partners
Alta Partners investment in Series B - Vir Biotechnology
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Vir Biotechnology
Alta Partners
Alta Partners investment in Venture Round - Vir Biotechnology
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Vir Biotechnology
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Venture Round - Vir Biotechnology
SoftBank Vision Fund
SoftBank Vision Fund investment in Venture Round - Vir Biotechnology
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Venture Round - Vir Biotechnology
Key Employee Changes
Official Site Inspections
http://www.vir.bio Semrush global rank: 1.34 M Semrush visits lastest month: 21.8 K
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
